OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
003006$16.3359

Chongqing Baiya Sanitary Products Co Ltd

Personal ProductsVerified

The company maintains a strong capital structure with a debt-to-equity ratio of 0.04, indicating minimal leverage and a conservative approach to financing. Its liquidity position is characterized as medium, with a current ratio of 2.07, suggesting the ability to meet short-term obligations but with limited excess cash. The valuation snapshot reveals a price-to-book ratio of 4.9 and a price-to-earnings ratio of 33.74, both of which are relatively high compared to typical benchmarks in the personal care sector. Profitability metrics show a return on equity (ROE) of 14.52% and a return on assets (ROA) of 9.98%, which are strong indicators of efficient asset utilization and effective management of equity capital. These figures are in line with the industry's preferred metrics for evaluating performance in the personal care segment. The company's gross profit margin of 54.24% (calculated from gross profit and revenue) is robust, reflecting a healthy pricing power and cost control. Geographically, the company's revenue is concentrated in China, with no disclosed international operations. This concentration may expose the company to domestic economic and regulatory risks, particularly in the consumer goods sector. The company operates in a single business segment, which simplifies its operations but also limits diversification benefits. The company's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. Analysts project a mean price target of 24.90 CNY, implying a potential upside of 52.4% from the current market price of 16.33 CNY. The mean recommendation of 1.57 suggests a generally positive outlook among analysts, with 3 strong-buy and 4 buy ratings. Risk factors include a negative net cash position after subtracting total debt, which could constrain the company's ability to invest in growth opportunities or weather economic downturns. The risk of dilution is assessed as low, with no significant changes in shares outstanding between basic and diluted figures. The company's free cash flow is negative at -66.8 million CNY, indicating that capital expenditures are outpacing operating cash flow. Recent events include the publication of the latest financial report, which provides updated figures on revenue, profitability, and capital structure. No material regulatory or legal events were disclosed in the latest filings, and the company appears to be operating within the bounds of standard industry practices.

30-day price · 003006(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyChongqing Baiya Sanitary Products Co Ltd
Ticker003006.SZ
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Chongqing Baiya Sanitary Products Co Ltd is a Chinese personal care products company that produces and sells feminine hygiene and baby care products, generating revenue primarily through retail and wholesale distribution channels.

Classification. The company is classified under the industry "Personal Products" within the business sector "Personal & Household Products & Services" and the economic sector "Consumer Non-Cyclicals," with a confidence level of 0.92.

The company maintains a strong capital structure with a debt-to-equity ratio of 0.04, indicating minimal leverage and a conservative approach to financing. Its liquidity position is characterized as medium, with a current ratio of 2.07, suggesting the ability to meet short-term obligations but with limited excess cash. The valuation snapshot reveals a price-to-book ratio of 4.9 and a price-to-earnings ratio of 33.74, both of which are relatively high compared to typical benchmarks in the personal care sector. Profitability metrics show a return on equity (ROE) of 14.52% and a return on assets (ROA) of 9.98%, which are strong indicators of efficient asset utilization and effective management of equity capital. These figures are in line with the industry's preferred metrics for evaluating performance in the personal care segment. The company's gross profit margin of 54.24% (calculated from gross profit and revenue) is robust, reflecting a healthy pricing power and cost control. Geographically, the company's revenue is concentrated in China, with no disclosed international operations. This concentration may expose the company to domestic economic and regulatory risks, particularly in the consumer goods sector. The company operates in a single business segment, which simplifies its operations but also limits diversification benefits. The company's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. Analysts project a mean price target of 24.90 CNY, implying a potential upside of 52.4% from the current market price of 16.33 CNY. The mean recommendation of 1.57 suggests a generally positive outlook among analysts, with 3 strong-buy and 4 buy ratings. Risk factors include a negative net cash position after subtracting total debt, which could constrain the company's ability to invest in growth opportunities or weather economic downturns. The risk of dilution is assessed as low, with no significant changes in shares outstanding between basic and diluted figures. The company's free cash flow is negative at -66.8 million CNY, indicating that capital expenditures are outpacing operating cash flow. Recent events include the publication of the latest financial report, which provides updated figures on revenue, profitability, and capital structure. No material regulatory or legal events were disclosed in the latest filings, and the company appears to be operating within the bounds of standard industry practices.
Key takeaways
  • The company has a strong ROE of 14.52% and ROA of 9.98%, indicating efficient use of equity and assets.
  • A price-to-book ratio of 4.9 and a price-to-earnings ratio of 33.74 suggest the stock is trading at a premium to its book and earnings value.
  • The company's liquidity position is medium, with a current ratio of 2.07, and a negative net cash position after debt.
  • Analysts project a mean price target of 24.90 CNY, implying a 52.4% upside from the current market price.
  • The company operates in a single business segment and is geographically concentrated in China, which may increase exposure to local economic and regulatory risks.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$3.49B
Gross profit$1.89B
Operating income$248.5M
Net income$208.0M
R&D
SG&A
D&A
SBC
Operating cash flow$199.4M
CapEx-$134.1M
Free cash flow-$66.8M
Total assets$2.08B
Total liabilities$651.8M
Total equity$1.43B
Cash & equivalents
Long-term debt$56.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$3.49B$248.5M$208.0M-$66.8M
FY-1$3.25B$327.9M$287.7M-$33.1M
FY-2$2.14B$280.1M$238.3M$82.4M
FY-3$1.61B$216.5M$187.3M$80.7M
FY-4$1.46B$255.2M$227.9M$17.8M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$2.08B$1.43B
FY-1$2.15B$1.45B
FY-2$1.88B$1.39B
FY-3$1.73B$1.28B
FY-4$1.55B$1.21B
PeriodOCFCapExFCFSBC
FY0$199.4M-$134.1M-$66.8M
FY-1$325.2M-$151.0M-$33.1M
FY-2$331.4M-$83.6M$82.4M
FY-3$233.6M-$28.3M$80.7M
FY-4$197.2M-$121.1M$17.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$1.06B$167.7M$143.7M
FQ-1$869.8M-$39.7M-$36.6M
FQ-2$858.8M$67.3M$56.5M
FQ-3$768.5M$70.3M$57.4M
FQ-4$995.4M$153.0M$130.6M
FQ-5$929.3M$50.0M$49.2M
FQ-6$792.7M$64.8M$58.8M
FQ-7$767.1M$96.6M$77.1M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$2.34B$1.58B$323.7M
FQ-1$2.08B$1.43B
FQ-2$2.10B$1.47B$334.6M
FQ-3$1.90B$1.41B
FQ-4$2.24B$1.58B$436.4M
FQ-5$2.15B$1.45B
FQ-6$1.93B$1.40B$328.9M
FQ-7$1.86B$1.34B
PeriodOCFCapExFCFSBC
FQ0$161.7M-$27.9M
FQ-1$199.4M-$134.1M
FQ-2$154.8M-$123.7M
FQ-3$67.7M-$83.6M
FQ-4$6.9M-$51.4M
FQ-5$325.2M-$151.0M
FQ-6$222.1M-$124.9M
FQ-7$190.9M-$79.5M
Valuation
Market price$16.33
Market cap$7.02B
Enterprise value$7.07B
P/E33.7
Reported non-GAAP P/E
EV/Revenue2.0
EV/Op income28.5
EV/OCF35.5
P/B4.9
P/Tangible book4.9
Tangible book$1.43B
Net cash-$56.8M
Current ratio2.1
Debt/Equity0.0
ROA10.0%
ROE14.5%
Cash conversion96.0%
CapEx/Revenue-3.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric003006Activity
Op margin7.1%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin6.0%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin54.2%60.1% medp25 60.1% · p75 60.1%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-3.8%-2.3% medp25 -4.4% · p75 -1.1%below median
Debt / equity4.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Observations
IR observations
Mean price target24.90 CNY
Median price target24.90 CNY
High price target25.00 CNY
Low price target24.80 CNY
Mean recommendation1.57 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count4.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.94 CNY
Last actual EPS0.48 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 00:55 UTCJob: 5ca3fac1